MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Cholangioscopy Using Narrow Band Imaging (NBI) in Patients With Primary Sclerosing Cholangitis (PSC) Undergoing Endoscopic Retrograde Cholangiopancreatogram (ERCP)

Completed

Conditions: Primary Sclerosing Cholangitis

First Posted Date: 2009-08-04

Last Posted Date: 2010-08-04

Lead Sponsor: Mayo Clinic

Target Recruit Count: 30

Registration Number: NCT00951327

Locations: 🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States

Evaluate Use of Mangosteen Juice Added to Usual Care in Reducing Risk of Recurrent Atrial Fibrillation

Phase 1

Terminated

Conditions: Atrial Fibrillation

Interventions: Drug: mangosteen juice
Drug: placebo juice

First Posted Date: 2009-08-04

Last Posted Date: 2016-03-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 143

Registration Number: NCT00951301

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy

Phase 1

Completed

Conditions: Unresectable Gallbladder Cancer
Cholangiocarcinoma of the Gallbladder
Unspecified Adult Solid Tumor, Protocol Specific
Localized Gallbladder Cancer

Interventions: Drug: everolimus
Drug: gemcitabine hydrochloride
Drug: cisplatin

First Posted Date: 2009-07-31

Last Posted Date: 2017-01-12

Lead Sponsor: Mayo Clinic

Target Recruit Count: 38

Registration Number: NCT00949949

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Imaging of Brain Amyloid Plaques in the Aging Population

Phase 4

Conditions: Vascular Dementia
Alzheimer's Disease
Dementia With Lewy Bodies
Frontotemporal Dementia

Interventions: Drug: Pittsburgh Compound B (C-11 PiB)
Drug: F-18 FDG
Drug: Tau (18-F-AV-1451)

First Posted Date: 2009-07-31

Last Posted Date: 2024-07-19

Lead Sponsor: Mayo Clinic

Target Recruit Count: 8000

Registration Number: NCT00950430

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Vitamin D and Genetics in Nutritional Rickets

Phase 4

Completed

Conditions: Nutritional Rickets

Interventions: Dietary Supplement: Vitamin D + Calcium
Dietary Supplement: Calcium
Dietary Supplement: Vitamin D2
Dietary Supplement: Vitamin D3

First Posted Date: 2009-07-30

Last Posted Date: 2012-07-04

Lead Sponsor: Mayo Clinic

Target Recruit Count: 109

Registration Number: NCT00949832

Locations: 🇳🇬
Jos University Teaching Hospital, Jos, Plateau, Nigeria

Wiser Choices in Osteoporosis Choice II: A Decision Aid for Patients and Clinicians

Not Applicable

Completed

Conditions: Osteoporosis
Osteopenia
Fragility Fractures

Interventions: Behavioral: FRAX + Decision Aid
Behavioral: FRAX estimated fracture risk

First Posted Date: 2009-07-30

Last Posted Date: 2016-02-02

Lead Sponsor: Mayo Clinic

Target Recruit Count: 79

Registration Number: NCT00949611

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Screening in Myocardial Perfusion Patients

Completed

Conditions: Breast Cancer

First Posted Date: 2009-07-22

Last Posted Date: 2013-02-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 322

Registration Number: NCT00943241

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast

Completed

Conditions: Breast Cancer

First Posted Date: 2009-07-22

Last Posted Date: 2012-01-25

Lead Sponsor: Mayo Clinic

Target Recruit Count: 110

Registration Number: NCT00943527

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Metabolic Syndrome Diagnosis and Education Trial

Not Applicable

Completed

Conditions: Metabolic Cardiovascular Syndrome

Interventions: Other: High-Tech Education
Other: Low-Tech Education

First Posted Date: 2009-07-22

Last Posted Date: 2010-10-15

Lead Sponsor: Mayo Clinic

Target Recruit Count: 74

Registration Number: NCT00943254

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)

Phase 1

Completed

Conditions: Fatigue
Primary Biliary Cirrhosis

Interventions: Drug: Modafinil

First Posted Date: 2009-07-22

Last Posted Date: 2012-01-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 40

Registration Number: NCT00943176

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy